Nerve Repair and Regeneration Market By Product (Biomaterials, Neuromodulation Surgery Devices), By Surgery (Direct Neuropathy, Nerve Grafting, Stem Cell Therapy, Neuromodulation Surgery): Global Opportunity Analysis and Industry Forecast, 2020-2030
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm-shifting strategies are required to develop treatments for neurological injury. Early diagnosis and treatment can prevent complications and permanent injuries. The techniques of nerve repair and regeneration aid to cure the disorders such as Alzheimer’s disease, Parkinson's disease, and other neurological disorders.
The major factors that enhance the market growth are an increase in the geriatric population, a rise in the incidence of neurological & epidemic disorders, and the launch of innovative products for nerve repair & regeneration. However, stringent regulatory requirements delay product approvals, thereby restraining the market growth.
The nerve repair and regeneration market are segmented on the basis of surgery, product, and region. By surgery, the market is classified into direct neuropathy, nerve grafting, stem cell therapy, and neuromodulation surgery. The direct neuropathy segment is further sub-categorized into epineural repair, perineural repair, and group fascicular repair. The nerve grafting segment is further sub-categorized into autografts, allografts, and xenografts. The neuromodulation surgery is further sub-categorized into external neuromodulation surgery and internal neuromodulation surgery.
By product, the market is divided into biomaterials and neuromodulation surgery devices. The biomaterials segment is further sub-categorized into nerve conduits, nerve protectors, nerve wraps, and nerve connectors. The neuromodulation surgery devices segment is further divided into external neuromodulation surgery and internal neuromodulation surgery. Externalneuromodulation surgery is further segmented into transcutaneous electrical nerve stimulation and transcranial magnetic stimulation. The internal neuromodulation surgery segment is divided into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and others. By region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA)
The major companies profiled in this report include Abbott Laboratories (U.S.), AxoGen Inc. (U.S.), Boston Scientific Incorporation (U.S.), Integra Lifesciences Corporation (U.S.), Medtronic plc (U.S.), NeuroPace, Inc., NeuroSigma, Polyganics B.V. (Netherlands
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nerve repair and regeneration market analysis from 2020 to 2030 to identify the prevailing nerve repair and regeneration market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the nerve repair and regeneration market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global nerve repair and regeneration market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Biomaterials
Neuromodulation Surgery Devices
By Surgery
Stem Cell Therapy
Neuromodulation Surgery
Direct Neuropathy
Nerve Grafting
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest Of Asia Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest Fo Lamea
Key Market Players
Abbott Laboratories
Boston scientific inc
Integra Lifesciences Corporation
Medtronic plc
Axogenic
Stryker Corporation
Checkpoint Surgical
Polyganics
Synovis Micro Companies Alliance
OrthoMed, Inc
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Biomaterials
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Neuromodulation Surgery Devices
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- CHAPTER 5: NERVE REPAIR AND REGENERATION MARKET, BY SURGERY
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Direct Neuropathy
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Nerve Grafting
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Stem Cell Therapy
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Neuromodulation Surgery
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- CHAPTER 6: NERVE REPAIR AND REGENERATION MARKET, BY REGION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by Product
- 6.2.3 North America Market size and forecast, by Surgery
- 6.2.4 North America Market size and forecast, by country
- 6.2.4.1 U.S.
- 6.2.4.1.1 Market size and forecast, by Product
- 6.2.4.1.2 Market size and forecast, by Surgery
- 6.2.4.2 Canada
- 6.2.4.2.1 Market size and forecast, by Product
- 6.2.4.2.2 Market size and forecast, by Surgery
- 6.2.4.3 Mexico
- 6.2.4.3.1 Market size and forecast, by Product
- 6.2.4.3.2 Market size and forecast, by Surgery
- 6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by Product
- 6.3.3 Europe Market size and forecast, by Surgery
- 6.3.4 Europe Market size and forecast, by country
- 6.3.4.1 Germany
- 6.3.4.1.1 Market size and forecast, by Product
- 6.3.4.1.2 Market size and forecast, by Surgery
- 6.3.4.2 France
- 6.3.4.2.1 Market size and forecast, by Product
- 6.3.4.2.2 Market size and forecast, by Surgery
- 6.3.4.3 U.K.
- 6.3.4.3.1 Market size and forecast, by Product
- 6.3.4.3.2 Market size and forecast, by Surgery
- 6.3.4.4 Italy
- 6.3.4.4.1 Market size and forecast, by Product
- 6.3.4.4.2 Market size and forecast, by Surgery
- 6.3.4.5 Spain
- 6.3.4.5.1 Market size and forecast, by Product
- 6.3.4.5.2 Market size and forecast, by Surgery
- 6.3.4.6 Rest of Europe
- 6.3.4.6.1 Market size and forecast, by Product
- 6.3.4.6.2 Market size and forecast, by Surgery
- 6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by Product
- 6.4.3 Asia-Pacific Market size and forecast, by Surgery
- 6.4.4 Asia-Pacific Market size and forecast, by country
- 6.4.4.1 Japan
- 6.4.4.1.1 Market size and forecast, by Product
- 6.4.4.1.2 Market size and forecast, by Surgery
- 6.4.4.2 China
- 6.4.4.2.1 Market size and forecast, by Product
- 6.4.4.2.2 Market size and forecast, by Surgery
- 6.4.4.3 Australia
- 6.4.4.3.1 Market size and forecast, by Product
- 6.4.4.3.2 Market size and forecast, by Surgery
- 6.4.4.4 India
- 6.4.4.4.1 Market size and forecast, by Product
- 6.4.4.4.2 Market size and forecast, by Surgery
- 6.4.4.5 South Korea
- 6.4.4.5.1 Market size and forecast, by Product
- 6.4.4.5.2 Market size and forecast, by Surgery
- 6.4.4.6 Rest Of Asia Pacific
- 6.4.4.6.1 Market size and forecast, by Product
- 6.4.4.6.2 Market size and forecast, by Surgery
- 6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by Product
- 6.5.3 LAMEA Market size and forecast, by Surgery
- 6.5.4 LAMEA Market size and forecast, by country
- 6.5.4.1 Brazil
- 6.5.4.1.1 Market size and forecast, by Product
- 6.5.4.1.2 Market size and forecast, by Surgery
- 6.5.4.2 Saudi Arabia
- 6.5.4.2.1 Market size and forecast, by Product
- 6.5.4.2.2 Market size and forecast, by Surgery
- 6.5.4.3 South Africa
- 6.5.4.3.1 Market size and forecast, by Product
- 6.5.4.3.2 Market size and forecast, by Surgery
- 6.5.4.4 Rest Fo Lamea
- 6.5.4.4.1 Market size and forecast, by Product
- 6.5.4.4.2 Market size and forecast, by Surgery
- CHAPTER 7: COMPANY LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Key developments
- CHAPTER 8: COMPANY PROFILES
- 8.1 Abbott Laboratories
- 8.1.1 Company overview
- 8.1.2 Company snapshot
- 8.1.3 Operating business segments
- 8.1.4 Product portfolio
- 8.1.5 Business performance
- 8.1.6 Key strategic moves and developments
- 8.2 Boston scientific inc
- 8.2.1 Company overview
- 8.2.2 Company snapshot
- 8.2.3 Operating business segments
- 8.2.4 Product portfolio
- 8.2.5 Business performance
- 8.2.6 Key strategic moves and developments
- 8.3 Integra Lifesciences Corporation
- 8.3.1 Company overview
- 8.3.2 Company snapshot
- 8.3.3 Operating business segments
- 8.3.4 Product portfolio
- 8.3.5 Business performance
- 8.3.6 Key strategic moves and developments
- 8.4 Medtronic plc
- 8.4.1 Company overview
- 8.4.2 Company snapshot
- 8.4.3 Operating business segments
- 8.4.4 Product portfolio
- 8.4.5 Business performance
- 8.4.6 Key strategic moves and developments
- 8.5 Axogenic
- 8.5.1 Company overview
- 8.5.2 Company snapshot
- 8.5.3 Operating business segments
- 8.5.4 Product portfolio
- 8.5.5 Business performance
- 8.5.6 Key strategic moves and developments
- 8.6 Stryker Corporation
- 8.6.1 Company overview
- 8.6.2 Company snapshot
- 8.6.3 Operating business segments
- 8.6.4 Product portfolio
- 8.6.5 Business performance
- 8.6.6 Key strategic moves and developments
- 8.7 Checkpoint Surgical
- 8.7.1 Company overview
- 8.7.2 Company snapshot
- 8.7.3 Operating business segments
- 8.7.4 Product portfolio
- 8.7.5 Business performance
- 8.7.6 Key strategic moves and developments
- 8.8 Polyganics
- 8.8.1 Company overview
- 8.8.2 Company snapshot
- 8.8.3 Operating business segments
- 8.8.4 Product portfolio
- 8.8.5 Business performance
- 8.8.6 Key strategic moves and developments
- 8.9 Synovis Micro Companies Alliance
- 8.9.1 Company overview
- 8.9.2 Company snapshot
- 8.9.3 Operating business segments
- 8.9.4 Product portfolio
- 8.9.5 Business performance
- 8.9.6 Key strategic moves and developments
- 8.10 OrthoMed, Inc
- 8.10.1 Company overview
- 8.10.2 Company snapshot
- 8.10.3 Operating business segments
- 8.10.4 Product portfolio
- 8.10.5 Business performance
- 8.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 2. NERVE REPAIR AND REGENERATION MARKET REVENUE, FOR BIOMATERIALS, BY REGION , 2020-2030,($MILLION)
- TABLE 3. NERVE REPAIR AND REGENERATION MARKET FOR BIOMATERIALS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 4. NERVE REPAIR AND REGENERATION MARKET REVENUE, FOR NEUROMODULATION SURGERY DEVICES, BY REGION , 2020-2030,($MILLION)
- TABLE 5. NERVE REPAIR AND REGENERATION MARKET FOR NEUROMODULATION SURGERY DEVICES BY COUNTRY, 2020-2030,($MILLION)
- TABLE 6. GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 7. NERVE REPAIR AND REGENERATION MARKET REVENUE, FOR DIRECT NEUROPATHY, BY REGION , 2020-2030,($MILLION)
- TABLE 8. NERVE REPAIR AND REGENERATION MARKET FOR DIRECT NEUROPATHY BY COUNTRY, 2020-2030,($MILLION)
- TABLE 9. NERVE REPAIR AND REGENERATION MARKET REVENUE, FOR NERVE GRAFTING, BY REGION , 2020-2030,($MILLION)
- TABLE 10. NERVE REPAIR AND REGENERATION MARKET FOR NERVE GRAFTING BY COUNTRY, 2020-2030,($MILLION)
- TABLE 11. NERVE REPAIR AND REGENERATION MARKET REVENUE, FOR STEM CELL THERAPY, BY REGION , 2020-2030,($MILLION)
- TABLE 12. NERVE REPAIR AND REGENERATION MARKET FOR STEM CELL THERAPY BY COUNTRY, 2020-2030,($MILLION)
- TABLE 13. NERVE REPAIR AND REGENERATION MARKET REVENUE, FOR NEUROMODULATION SURGERY, BY REGION , 2020-2030,($MILLION)
- TABLE 14. NERVE REPAIR AND REGENERATION MARKET FOR NEUROMODULATION SURGERY BY COUNTRY, 2020-2030,($MILLION)
- TABLE 15. NERVE REPAIR AND REGENERATION MARKET, BY REGION, 2020-2030,($MILLION)
- TABLE 16. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 17. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 18. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 19. U.S. NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 20. U.S. NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 21. CANADA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 22. CANADA NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 23. MEXICO NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 24. MEXICO NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 25. EUROPE NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 26. EUROPE NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 27. EUROPE NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 28. GERMANY NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 29. GERMANY NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 30. FRANCE NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 31. FRANCE NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 32. U.K. NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 33. U.K. NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 34. ITALY NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 35. ITALY NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 36. SPAIN NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 37. SPAIN NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 38. REST OF EUROPE NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 39. REST OF EUROPE NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 40. ASIA-PACIFIC NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 41. ASIA-PACIFIC NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 42. ASIA-PACIFIC NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 43. JAPAN NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 44. JAPAN NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 45. CHINA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 46. CHINA NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 47. AUSTRALIA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 48. AUSTRALIA NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 49. INDIA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 50. INDIA NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 51. SOUTH KOREA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 52. SOUTH KOREA NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 53. REST OF ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 54. REST OF ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 55. LAMEA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 56. LAMEA NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 57. LAMEA NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 58. BRAZIL NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 59. BRAZIL NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 60. SAUDI ARABIA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 61. SAUDI ARABIA NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 62. SOUTH AFRICA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 63. SOUTH AFRICA NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 64. REST FO LAMEA NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2020-2030,($MILLION)
- TABLE 65. REST FO LAMEA NERVE REPAIR AND REGENERATION MARKET, BY SURGERY, 2020-2030,($MILLION)
- TABLE 66.ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 67.ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 68.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 69.ABBOTT LABORATORIES: NET SALES,
- TABLE 70.ABBOTT LABORATORIES: KEY STRATERGIES
- TABLE 71.BOSTON SCIENTIFIC INC: COMPANY SNAPSHOT
- TABLE 72.BOSTON SCIENTIFIC INC: OPERATING SEGMENTS
- TABLE 73.BOSTON SCIENTIFIC INC: PRODUCT PORTFOLIO
- TABLE 74.BOSTON SCIENTIFIC INC: NET SALES,
- TABLE 75.BOSTON SCIENTIFIC INC: KEY STRATERGIES
- TABLE 76.INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
- TABLE 77.INTEGRA LIFESCIENCES CORPORATION: OPERATING SEGMENTS
- TABLE 78.INTEGRA LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
- TABLE 79.INTEGRA LIFESCIENCES CORPORATION: NET SALES,
- TABLE 80.INTEGRA LIFESCIENCES CORPORATION: KEY STRATERGIES
- TABLE 81.MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 82.MEDTRONIC PLC: OPERATING SEGMENTS
- TABLE 83.MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 84.MEDTRONIC PLC: NET SALES,
- TABLE 85.MEDTRONIC PLC: KEY STRATERGIES
- TABLE 86.AXOGENIC: COMPANY SNAPSHOT
- TABLE 87.AXOGENIC: OPERATING SEGMENTS
- TABLE 88.AXOGENIC: PRODUCT PORTFOLIO
- TABLE 89.AXOGENIC: NET SALES,
- TABLE 90.AXOGENIC: KEY STRATERGIES
- TABLE 91.STRYKER CORPORATION: COMPANY SNAPSHOT
- TABLE 92.STRYKER CORPORATION: OPERATING SEGMENTS
- TABLE 93.STRYKER CORPORATION: PRODUCT PORTFOLIO
- TABLE 94.STRYKER CORPORATION: NET SALES,
- TABLE 95.STRYKER CORPORATION: KEY STRATERGIES
- TABLE 96.CHECKPOINT SURGICAL: COMPANY SNAPSHOT
- TABLE 97.CHECKPOINT SURGICAL: OPERATING SEGMENTS
- TABLE 98.CHECKPOINT SURGICAL: PRODUCT PORTFOLIO
- TABLE 99.CHECKPOINT SURGICAL: NET SALES,
- TABLE 100.CHECKPOINT SURGICAL: KEY STRATERGIES
- TABLE 101.POLYGANICS: COMPANY SNAPSHOT
- TABLE 102.POLYGANICS: OPERATING SEGMENTS
- TABLE 103.POLYGANICS: PRODUCT PORTFOLIO
- TABLE 104.POLYGANICS: NET SALES,
- TABLE 105.POLYGANICS: KEY STRATERGIES
- TABLE 106.SYNOVIS MICRO COMPANIES ALLIANCE: COMPANY SNAPSHOT
- TABLE 107.SYNOVIS MICRO COMPANIES ALLIANCE: OPERATING SEGMENTS
- TABLE 108.SYNOVIS MICRO COMPANIES ALLIANCE: PRODUCT PORTFOLIO
- TABLE 109.SYNOVIS MICRO COMPANIES ALLIANCE: NET SALES,
- TABLE 110.SYNOVIS MICRO COMPANIES ALLIANCE: KEY STRATERGIES
- TABLE 111.ORTHOMED, INC: COMPANY SNAPSHOT
- TABLE 112.ORTHOMED, INC: OPERATING SEGMENTS
- TABLE 113.ORTHOMED, INC: PRODUCT PORTFOLIO
- TABLE 114.ORTHOMED, INC: NET SALES,
- TABLE 115.ORTHOMED, INC: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.NERVE REPAIR AND REGENERATION MARKET SEGMENTATION
- FIGURE 2.NERVE REPAIR AND REGENERATION MARKET,2020-2030
- FIGURE 3.NERVE REPAIR AND REGENERATION MARKET,2020-2030
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.NERVE REPAIR AND REGENERATION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.NERVE REPAIR AND REGENERATION MARKET,BY PRODUCT,2020(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF BIOMATERIALS NERVE REPAIR AND REGENERATION MARKET,2020-2030(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF NEUROMODULATION SURGERY DEVICES NERVE REPAIR AND REGENERATION MARKET,2020-2030(%)
- FIGURE 15.NERVE REPAIR AND REGENERATION MARKET,BY SURGERY,2020(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DIRECT NEUROPATHY NERVE REPAIR AND REGENERATION MARKET,2020-2030(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF NERVE GRAFTING NERVE REPAIR AND REGENERATION MARKET,2020-2030(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF STEM CELL THERAPY NERVE REPAIR AND REGENERATION MARKET,2020-2030(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF NEUROMODULATION SURGERY NERVE REPAIR AND REGENERATION MARKET,2020-2030(%)
- FIGURE 20.NERVE REPAIR AND REGENERATION MARKET BY REGION,2020
- FIGURE 21.U.S. NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 22.CANADA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 23.MEXICO NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 24.GERMANY NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 25.FRANCE NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 26.U.K. NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 27.ITALY NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 28.SPAIN NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 29.REST OF EUROPE NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 30.JAPAN NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 31.CHINA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 32.AUSTRALIA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 33.INDIA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 34.SOUTH KOREA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 35.REST OF ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 36.BRAZIL NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 37.SAUDI ARABIA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 38.SOUTH AFRICA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 39.REST FO LAMEA NERVE REPAIR AND REGENERATION MARKET,2020-2030($MILLION)
- FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 43.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 44.COMPETITIVE DASHBOARD
- FIGURE 45.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 46.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
- FIGURE 47.BOSTON SCIENTIFIC INC.: NET SALES ,($MILLION)
- FIGURE 48.INTEGRA LIFESCIENCES CORPORATION.: NET SALES ,($MILLION)
- FIGURE 49.MEDTRONIC PLC.: NET SALES ,($MILLION)
- FIGURE 50.AXOGENIC.: NET SALES ,($MILLION)
- FIGURE 51.STRYKER CORPORATION.: NET SALES ,($MILLION)
- FIGURE 52.CHECKPOINT SURGICAL.: NET SALES ,($MILLION)
- FIGURE 53.POLYGANICS.: NET SALES ,($MILLION)
- FIGURE 54.SYNOVIS MICRO COMPANIES ALLIANCE.: NET SALES ,($MILLION)
- FIGURE 55.ORTHOMED, INC.: NET SALES ,($MILLION)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook